Kurzfassung

A Multicenter; Randomized , Double-Blind, Placebo Cotrolled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standrat of Care in Subjects with Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome